Mortality Rates for Pneumonia and Influenza Vary by Geographical Area
Researchers assessed whether there was geographic variation in racial disparity in influenza and pneumonia.
Researchers assessed whether there was geographic variation in racial disparity in influenza and pneumonia.
Investigators used precision surveillance by combining genomic sequencing and conventional surveillance to delineate a nosocomial viral outbreak; they believe the findings of their study are applicable to a range of respiratory pathogens, including SARS-CoV-2.
Either the trivalent adjuvanted inactivated influenza vaccine (aIIV3) or the trivalent high-dose inactivated influenza vaccine (HD-IIV3) is safe to use in older adults.
Severe coronavirus disease 2019 (COVID-19) is associated with immunothrombotic, neutrophil-containing vessel occlusions in the lung.
For patients with high-risk CVD, high-dose trivalent inactivated influenza vaccination does not reduce cardiopulmonary hospitalization or all-cause mortality.
Study authors evaluated the performance of symptom-based definitions to detect influenza in a cohort of pregnant women in India, Peru, and Thailand.
Older adults are less likely to get a COVID-19 vaccine than a flu vaccine, according to the University of Michigan National Poll on Healthy Aging.
Several previously FDA-approved medicines were approved for additional uses in November 2020.
Study authors identified and evaluated a statistical signal for an increased risk of Guillain-Barré Syndrome in days 1-42 after 2018-2019 high-dose influenza vaccine administration.
The 2018 to 2019 influenza vaccine effectiveness was about 40% to 60% for reducing pediatric influenza A-associated hospitalizations.